InsidersTradesSigma
Track the BIOCARTIS stock price and the full management transaction log of the company, a listed issuer based in Belgium. Shares trade on the BE market, under the oversight of FSMA. Operating in the Health Care sector, BIOCARTIS has recorded 1 insider filings. The latest transaction was disclosed on 10 May 2023 (Purchase). Among the most active insiders: South Bay Ventures. The full history is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
BIOCARTIS is a company focused on developing molecular diagnostic solutions. It offers rapid and accurate tests for the diagnosis of diseases, including cancer.